Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för trichlormethiazide. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

7 träffar

Bibliografisk träff 2018-04-03

Methyldopa blocks MHC class II binding to disease-specific antigens in autoimmune diabetes.

Ostrov DA, Alkanani A, McDaniel KA, Case S, Baschal EE, Pyle L, Ellis S, Pöllinger B, Seidl KJ, Shah VN, Garg SK, Atkinson MA, Gottlieb PA, Michels AW.

J Clin Invest · research support, non-u.s. gov't; research-article; journal article; research support, n.i.h., extramural · DOI 10.1172/jci97739

Bibliografisk träff 2017-02-06

Drugs and drug-like molecules can modulate the function of mucosal-associated invariant T cells.

Keller AN, Eckle SB, Xu W, Liu L, Hughes VA, Mak JY, Meehan BS, Pediongco T, Birkinshaw RW, Chen Z, Wang H, D'Souza C, Kjer-Nielsen L, Gherardin NA, Godfrey DI, Kostenko L, Corbett AJ, Purcell AW, Fairlie DP, McCluskey J, Rossjohn J.

Nat Immunol · research support, non-u.s. gov't; journal article · DOI 10.1038/ni.3679

Bibliografisk träff 2016-12-22

Olmesartan with azelnidipine versus with trichlormethiazide on home blood pressure variability in patients with type II diabetes mellitus.

Ushigome E, Matsumoto S, Oyabu C, Ushigome H, Yokota I, Hasegawa G, Nakamura N, Tanaka M, Yamazaki M, Fukui M.

J Am Soc Hypertens · comparative study; journal article · DOI 10.1016/j.jash.2016.12.004

Bibliografisk träff 2015-05-04

Comparison of Azelnidipine and Trichlormethiazide in Japanese Type 2 Diabetic Patients with Hypertension: The COAT Randomized Controlled Trial.

Takihata M, Nakamura A, Kondo Y, Kawasaki S, Kimura M, Terauchi Y.

PLoS One · research support, non-u.s. gov't; research-article; multicenter study; randomized controlled trial; journal article · DOI 10.1371/journal.pone.0125519

Bibliografisk träff 2015-01-05

Identification of trichlormethiazide as a Mdr1a/b gene expression enhancer via a dual secretion-based promoter assay.

Schulze S, Reinhardt S, Freese C, Schmitt U, Endres K.

Pharmacol Res Perspect · research-article; journal article · DOI 10.1002/prp2.109

Bibliografisk träff 2014-03-28

Combining irbesartan and trichlormethiazide enhances blood pressure reduction via inhibition of sympathetic activity without adverse effects on metabolism in hypertensive rats with metabolic syndrome.

Nishihara M, Hirooka Y, Sunagawa K.

Clin Exp Hypertens · research support, non-u.s. gov't; journal article · DOI 10.3109/10641963.2014.897719

Bibliografisk träff 2011-05-23

Adverse effect profile of trichlormethiazide: a retrospective observational study.

Takahashi Y, Nishida Y, Nakayama T, Asai S.

Cardiovasc Diabetol · research support, non-u.s. gov't; research-article; journal article · DOI 10.1186/1475-2840-10-45